Aptorum Group Ltd (APM) — 6-K Filings

6-K Filings (15)

• Aptorum Group Ltd. Announces Share and Warrant Offering — Oct 16, 2025 Risk: medium
  On October 10, 2025, Aptorum Group Limited entered into a securities purchase agreement with institutional investors to sell 1,000,000 Class A ordinary shares.
• Aptorum Group Enters Agreement with DiamiR Biosciences — Oct 15, 2025 Risk: low
  Aptorum Group Ltd. (APM) announced on October 15, 2025, that it has entered into an Agreement and Plan with DiamiR Biosciences Corp. This filing is a Report of
• Aptorum Group Ltd Files 6-K Report — Oct 8, 2025 Risk: low
  Aptorum Group Ltd filed a Form 6-K on October 8, 2025, reporting for the period ending June 30, 2025. The filing is a report of a foreign private issuer and ind
• Aptorum Group Ltd. Files 6-K with Interim Financials — Oct 3, 2025 Risk: low
  Aptorum Group Ltd. is filing a Form 6-K on October 3, 2025, to provide its six-month interim consolidated financial statements for the period ended June 30, 202
• Aptorum Group Merges with DiamiR Biosciences — Sep 10, 2025 Risk: medium
  Aptorum Group Ltd. announced on September 10, 2025, that it entered into an Agreement and Plan of Merger on July 14, 2025, with DiamiR Biosciences Corp. This me
• Aptorum Group Merges with DiamiR Biosciences — Jul 22, 2025 Risk: medium
  Aptorum Group Ltd. announced on July 14, 2025, that it entered into a Merger Agreement with DiamiR Biosciences Corp. Under the terms of the agreement, Aptorum w
• Aptorum Group Gets Nasdaq Bid Price Deficiency Notice — Apr 16, 2025 Risk: medium
  Aptorum Group Ltd. received a notification from Nasdaq on April 16, 2025, stating that the company's common stock had a closing bid price of less than $1.00 for
• Aptorum Group Raises $3.07M in Direct Offering — Jan 7, 2025 Risk: medium
  On January 2, 2025, Aptorum Group Limited completed a registered direct offering, selling 1,535,000 Class A ordinary shares at $2.00 per share. This transaction
• Aptorum Group Ltd. Files Interim Financials — Dec 20, 2024 Risk: low
  Aptorum Group Ltd. is filing a Form 6-K on December 20, 2024, to provide its six-month interim consolidated financial statements for the period ending June 30,
• Aptorum Group Holds 2024 Shareholder Meeting — Dec 11, 2024 Risk: low
  Aptorum Group Limited held its 2024 annual meeting of shareholders on December 10, 2024. Shareholders voted on two proposals, with a quorum established by the r
• Aptorum Group Ltd. Files Proxy for 2024 Annual Meeting — Nov 8, 2024 Risk: low
  Aptorum Group Ltd. is filing a Form 6-K to provide its proxy statement for the 2024 annual general meeting of shareholders, scheduled for December 10, 2024, at
• Aptorum Group Directors Resign; Arner to Chair Audit Committee — Nov 1, 2024 Risk: low
  On October 31, 2024, Dr. Mirko Scherer and Mr. Charles Bathurst resigned from Aptorum Group Limited's Board of Directors for personal reasons. Following these r
• Aptorum Group Ltd Appoints New Head of Finance — Aug 9, 2024 Risk: medium
  Aptorum Group Ltd announced the resignation of Martin Siu as Head of Finance, effective August 7, 2024, due to personal reasons. Wong Kwok Kuen has been appoint
• Aptorum Group Ltd. Merges with YOOV Group Holding Limited — May 31, 2024 Risk: medium
  Aptorum Group Ltd. announced on May 31, 2024, that it entered into an Agreement and Plan of Merger on March 1, 2024, with YOOV Group Holding Limited. This filin
• Aptorum Group Ltd. Announces Merger Agreement with YOOV Group — Mar 6, 2024 Risk: medium
  On March 1, 2024, Aptorum Group Limited entered into an Agreement and Plan of Merger with YOOV Group Holding Limited. This merger was unanimously approved by th

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX